Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,109 | 646 | 99.0% |
| Education | $117.20 | 4 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,520 | 80 | $0 (2024) |
| Amgen Inc. | $982.45 | 53 | $0 (2024) |
| Merck Sharp & Dohme LLC | $970.23 | 77 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $781.23 | 45 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $735.82 | 28 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $639.66 | 31 | $0 (2023) |
| Lilly USA, LLC | $627.82 | 23 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $431.42 | 21 | $0 (2022) |
| ABBVIE INC. | $416.61 | 28 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $402.54 | 25 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,373 | 55 | AstraZeneca Pharmaceuticals LP ($228.13) |
| 2023 | $1,877 | 80 | Novo Nordisk Inc ($437.01) |
| 2022 | $1,236 | 64 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($163.34) |
| 2021 | $1,581 | 90 | AbbVie Inc. ($272.65) |
| 2020 | $1,216 | 74 | Novo Nordisk Inc ($243.97) |
| 2019 | $1,064 | 56 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($215.74) |
| 2018 | $1,703 | 92 | Daiichi Sankyo Inc. ($229.87) |
| 2017 | $2,176 | 139 | Merck Sharp & Dohme Corporation ($281.54) |
All Payment Transactions
650 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $126.11 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 12/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Diabetes Care | ||||||
| 11/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/22/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Bone Health | ||||||
| 10/02/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/26/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Endocrinology | ||||||
| 09/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Obesity | ||||||
| 09/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Inflammation | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/19/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Obesity | ||||||
| 08/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: Inflammation | ||||||
| 08/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Oncology | ||||||
| 07/29/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $69.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Endocrinology | ||||||
| 07/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/01/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 759 | 1,766 | $188,990 | $102,918 |
| 2022 | 12 | 613 | 1,432 | $162,764 | $92,092 |
| 2021 | 9 | 547 | 1,151 | $145,849 | $85,259 |
| 2020 | 12 | 621 | 1,506 | $185,134 | $98,523 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 59 | 376 | $38,728 | $22,130 | 57.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 159 | 375 | $37,500 | $21,429 | 57.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 128 | 128 | $17,920 | $15,267 | 85.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 61 | 78 | $23,322 | $9,984 | 42.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 102 | $15,300 | $8,696 | 56.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 39 | 92 | $13,800 | $8,148 | 59.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 54 | 66 | $9,900 | $3,953 | 39.9% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 21 | 111 | $6,105 | $3,231 | 52.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 22 | 65 | $4,875 | $2,309 | 47.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 16 | 48 | $3,600 | $1,682 | 46.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 25 | $2,500 | $1,152 | 46.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $2,400 | $1,070 | 44.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 29 | $2,175 | $1,010 | 46.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 11 | 11 | $1,815 | $933.68 | 51.4% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 13 | 15 | $2,250 | $519.60 | 23.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 46 | $2,530 | $465.34 | 18.4% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 11 | 11 | $550.00 | $368.39 | 67.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $550.00 | $312.84 | 56.9% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 15 | 15 | $675.00 | $200.10 | 29.6% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 16 | 146 | $2,495 | $57.64 | 2.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 46 | 418 | $43,054 | $22,688 | 52.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 135 | 317 | $31,700 | $19,654 | 62.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 115 | 175 | $26,250 | $14,902 | 56.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 111 | 111 | $15,540 | $13,831 | 89.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 46 | 64 | $19,136 | $9,572 | 50.0% |
About Dr. Michael Posey, MD
Dr. Michael Posey, MD is a Internal Medicine healthcare provider based in Germantown, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194700146.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Posey, MD has received a total of $12,226 in payments from pharmaceutical and medical device companies, with $1,373 received in 2024. These payments were reported across 650 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($12,109).
As a Medicare-enrolled provider, Posey has provided services to 2,540 Medicare beneficiaries, totaling 5,855 services with total Medicare billing of $378,791. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Germantown, TN
- Active Since 12/13/2005
- Last Updated 04/17/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1194700146
Products in Payments
- Ozempic (Drug) $764.56
- FARXIGA (Drug) $467.45
- ENTRESTO (Drug) $417.29
- BELSOMRA (Drug) $394.48
- CYCLOSET (Drug) $382.25
- LEQVIO (Drug) $363.94
- Otezla (Drug) $360.68
- NUEDEXTA (Drug) $357.80
- DALVANCE (Drug) $333.98
- XARELTO (Drug) $306.91
- JANUVIA (Drug) $257.24
- Morphabond ER (Drug) $252.17
- XIFAXAN (Drug) $242.49
- SOLIQUA (Drug) $239.85
- ELIQUIS (Drug) $236.18
- Vascepa (Drug) $233.67
- Prolia (Biological) $224.74
- TRULICITY (Drug) $224.67
- MOUNJARO (Drug) $209.60
- Rybelsus (Drug) $208.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Germantown
Dr. David Lan, Md, MD
Internal Medicine — Payments: $221,102
Dr. Ari Vanderwalde, M.d, M.D
Internal Medicine — Payments: $48,555
Dr. John Trujillo, M.d, M.D
Internal Medicine — Payments: $28,212
Dr. Vinu Ganti, Md, MD
Internal Medicine — Payments: $20,803
Dr. Mark Goldstein, Md, MD
Internal Medicine — Payments: $20,002
James Ensor, Md, MD
Internal Medicine — Payments: $13,746